IQVIA

The eResearch Technology company IQVIA was targeted in a ransomware attack that affected the clinical trial for vaccines.

They were locked out of their data and had to track their patients with pen and paper.

The attack had a limited impact on our clinical trials operations and the systems were soon restored.

Source: https://www.nytimes.com/2020/10/03/technology/clinical-trials-ransomware-attack-drugmakers.html

TPRM report: https://scoringcyber.rankiteo.com/company/iqvia

"id": "iqv125614222",
"linkid": "iqvia",
"type": "Ransomware",
"date": "10/2020",
"severity": "80",
"impact": "2",
"explanation": "Attack limited on finance or reputation"

{'affected_entities': [{'industry': 'Healthcare',
                        'name': 'IQVIA',
                        'type': 'eResearch Technology company'}],
 'description': 'The eResearch Technology company IQVIA was targeted in a '
                'ransomware attack that affected the clinical trial for '
                'vaccines. They were locked out of their data and had to track '
                'their patients with pen and paper. The attack had a limited '
                'impact on our clinical trials operations and the systems were '
                'soon restored.',
 'impact': {'operational_impact': ['Limited impact on clinical trials '
                                   'operations'],
            'systems_affected': ['Clinical trial systems']},
 'ransomware': {'data_encryption': ['Data was locked']},
 'response': {'recovery_measures': ['Systems were soon restored']},
 'title': 'Ransomware Attack on IQVIA',
 'type': 'Ransomware'}